United Kingdom· GB-APID-3156911000001105
Audicort ear drops
A medicinal product containing neomycin + triamcinolone, registered in United Kingdom by Mercury Pharma Group Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Neomycin + Triamcinolone
- Manufacturer
- Mercury Pharma Group Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Neomycin + triamcinolone in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5e9d7a0b-2642-4116-a4c1-ce4f730d40a5 GET /v1/drugs/5e9d7a0b-2642-4116-a4c1-ce4f730d40a5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "3156911000001105",
"desc": "Audicort ear drops (Mercury Pharma Group Ltd)",
"form": "Ear drops",
"vpid": "42193011000001102",
"source": "dmd",
"vtm_id": "776890000",
"strength": "3.5 mg",
"substance": "Neomycin + Triamcinolone",
"ingredient": "Neomycin",
"supplier_code": "151601000001102"
}See everything about neomycin + triamcinolone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.